Segall Bryant & Hamill’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7M	Buy	500,559 +219,420	+78%	+$3.07M	0.1%	278
2025 Q1	$3.82M	Sell	281,139 -7,936	-3%	-$108K	0.06%	348
2024 Q4	$5.89M	Buy	+289,075	New	+$5.89M	0.08%	304